These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37595489)

  • 81. Long-term outcome and relapse patterns in Ewing sarcoma patients with extensive lung/pleural metastases after a complete response to systemic therapy.
    Xu J; Zhi X; Xie L; Sun X; Liu X; Liu K; Guo W
    BMC Cancer; 2022 May; 22(1):500. PubMed ID: 35524212
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Outcomes of extraskeletal vs. skeletal Ewing sarcoma patients treated with standard chemotherapy protocol.
    Salah S; Abuhijla F; Ismail T; Yaser S; Sultan I; Halalsheh H; Shehadeh A; Abdelal S; Almousa A; Jaber O; Abu-Hijlih R
    Clin Transl Oncol; 2020 Jun; 22(6):878-883. PubMed ID: 31429039
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Primary cutaneous Ewing sarcoma: a systematic review focused on treatment and outcome.
    Delaplace M; Lhommet C; de Pinieux G; Vergier B; de Muret A; Machet L
    Br J Dermatol; 2012 Apr; 166(4):721-6. PubMed ID: 22098102
    [TBL] [Abstract][Full Text] [Related]  

  • 84. High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.
    Vijayasekharan K; Ramanathan S; Chinnaswamy G; Prasad M; Gulia A; Janu A; Rekhi B; Ramadwar M; Khanna N; Laskar S; Puranadare N; Bajpai J; Puri A; Banavali S; Vora T
    J Adolesc Young Adult Oncol; 2021 Apr; 10(2):185-192. PubMed ID: 32706630
    [No Abstract]   [Full Text] [Related]  

  • 85. Efficacy of Local Control Strategies for Ewing Sarcoma After Neoadjuvant Chemotherapy: A Network Meta-analysis.
    Zhu H; Li Y; Xie X; Zhang S; Xue Y; Fan T
    Indian Pediatr; 2020 Jun; 57(6):527-532. PubMed ID: 32221054
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy.
    Gupta AA; Pappo A; Saunders N; Hopyan S; Ferguson P; Wunder J; O'Sullivan B; Catton C; Greenberg M; Blackstein M
    Cancer; 2010 Jul; 116(13):3189-94. PubMed ID: 20564643
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database.
    Nussbaum DP; Rushing CN; Lane WO; Cardona DM; Kirsch DG; Peterson BL; Blazer DG
    Lancet Oncol; 2016 Jul; 17(7):966-975. PubMed ID: 27210906
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pelvic Ewing sarcoma: Should all patients receive pre-operative radiotherapy, or should it be delivered selectively?
    Lex JR; Kurisunkal V; Kaneuchi Y; Fujiwara T; Sherriff J; Wigley C; Stevenson JD; Parry MC; Jeys LM
    Eur J Surg Oncol; 2021 Oct; 47(10):2618-2626. PubMed ID: 34030919
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [
    Annovazzi A; Ferraresi V; Anelli V; Covello R; Vari S; Zoccali C; Biagini R; Sciuto R
    Eur Radiol; 2021 Sep; 31(9):7012-7021. PubMed ID: 33715090
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
    Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966
    [TBL] [Abstract][Full Text] [Related]  

  • 91. High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.
    Koch R; Gelderblom H; Haveman L; Brichard B; Jürgens H; Cyprova S; van den Berg H; Hassenpflug W; Raciborska A; Ek T; Baumhoer D; Egerer G; Eich HT; Renard M; Hauser P; Burdach S; Bovee J; Bonar F; Reichardt P; Kruseova J; Hardes J; Kühne T; Kessler T; Collaud S; Bernkopf M; Butterfaß-Bahloul T; Dhooge C; Bauer S; Kiss J; Paulussen M; Hong A; Ranft A; Timmermann B; Rascon J; Vieth V; Kanerva J; Faldum A; Metzler M; Hartmann W; Hjorth L; Bhadri V; Dirksen U
    J Clin Oncol; 2022 Jul; 40(21):2307-2320. PubMed ID: 35427190
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Surgical treatment for pelvic Ewing sarcoma: What is a safe and functional acetabular reconstruction when combined with modern multidisciplinary treatments?
    Fujiwara T; Lex JR; Stevenson JD; Tsuda Y; Clark R; Parry MC; Grimer RJ; Jeys LM
    J Surg Oncol; 2019 Nov; 120(6):985-993. PubMed ID: 31381161
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prognostic Factors and Clinical Outcomes in Extraskeletal Ewing Sarcoma: A Cohort Study.
    Mathew J; Arjunan R; Dasappa A; Namachivayam A
    Ann Surg Oncol; 2023 May; 30(5):3084-3094. PubMed ID: 36564656
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Mohanti BK; Sharma MC; Vishnubhatla S; Bakhshi S
    J Surg Oncol; 2015 May; 111(6):683-9. PubMed ID: 25557999
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Predictors of Recurrence and Patterns of Initial Failure in Localized Ewing Sarcoma: A Contemporary 20-Year Experience.
    Stachelek GC; Ligon JA; Vogel J; Levin AS; Llosa NJ; Ladle BH; Meyer CF; Terezakis SA; Morris CD; Ladra MM; Pratilas CA
    Sarcoma; 2021; 2021():6681741. PubMed ID: 33953640
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Survival and treatment in older patients with ewing sarcoma: an analysis of the national cancer database.
    Braaten M; Braaten J; Chaddha J; Hu R; Lanoue C; Silberstein P; Tauseef A; Asghar N; Mirza M
    Eur J Med Res; 2024 Jan; 29(1):29. PubMed ID: 38183148
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Real-world experiences in patients with Ewing sarcoma treated at a specialist centre in Turkey.
    Çakmakcı S; Sarı N; Atasever Akkaş E; Yıldız F; Karakaya E; Kaya B; Şafak Güngör B; Berna Çakmak Öksüzoğlu Ö; Ergürhan İlhan İ
    J Bone Oncol; 2024 Aug; 47():100619. PubMed ID: 39109280
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Outcomes of Ewing sarcoma in adults over 40 years of age from a low-middle income country.
    Panda G; Chandrasekharan A; Das S; Bhargava P; Srinivas S; Laskar S; Mokal S; Rekhi B; Khanna N; Menon N; Patil V; Noronha V; Joshi A; Prabhash K; Banavali SD; Gupta S; Bajpai J
    Ecancermedicalscience; 2022; 16():1361. PubMed ID: 35685954
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Factors Influencing the Outcome of Patients with Primary Ewing Sarcoma of the Sacrum.
    Rechl V; Ranft A; Bhadri V; Brichard B; Collaud S; Cyprova S; Eich H; Ek T; Gelderblom H; Hardes J; Haveman LM; Hartmann W; Hauser P; Heesen P; Jürgens H; Kanerva J; Kühne T; Raciborska A; Rascon J; Streitbürger A; Uhlenbruch Y; Timmermann B; Kersting J; Pham MT; Dirksen U
    Sarcoma; 2024; 2024():4751914. PubMed ID: 38524902
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial.
    Heesen P; Ranft A; Bhadri V; Brichard B; Collaud S; Cyprova S; Eich H; Ek T; Gelderblom H; Hardes J; Haveman L; Jabar S; Hartmann W; Andreou D; Hauser P; Kersting J; Juergens H; Kanerva J; Kühne T; Raciborska A; Rascon J; Streitbürger A; Timmermann B; Uhlenbruch Y; Dirksen U
    Eur J Cancer; 2023 Oct; 192():113260. PubMed ID: 37595489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.